AJP - Endo Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 283: E12-E19, 2002. First published March 5, 2002; doi:10.1152/ajpendo.00429.2001
0193-1849/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/1/E12    most recent
00429.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (70)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boden, G.
Right arrow Articles by Mozzoli, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boden, G.
Right arrow Articles by Mozzoli, M.
Vol. 283, Issue 1, E12-E19, July 2002

FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis

Guenther Boden1, Peter Cheung1, T. Peter Stein2, Karen Kresge1, and Maria Mozzoli1

1 Division of Endocrinology/Diabetes/Metabolism and the General Clinical Research Center, Temple University Health Sciences Center, Philadelphia, Pennsylvania 19140; and 2 Department of Surgery, University of Medicine and Dentistry of New Jersey, School of Osteopathic Medicine, Stratford, New Jersey 08084

Free fatty acids (FFA) have been shown to inhibit insulin suppression of endogenous glucose production (EGP). To determine whether this is the result of stimulation by FFA of gluconeogenesis (GNG) or glycogenolysis (GL) or a combination of both, we have determined rates of GNG and GL (with 2H2O) and EGP in 16 healthy nondiabetic volunteers (11 males, 5 females) during euglycemic-hyperinsulinemic (~450 pM) clamping performed either with or without simultaneous intravenous infusion of lipid plus heparin. During insulin infusion, FFA decreased from 571 to 30 µmol/l (P < 0.001), EGP from 15.7 to 2.0 µmol · kg-1 · min-1 (P < 0.01), GNG from 8.2 to 3.7 µmol · kg-1 · min-1 (P < 0.05), and GL from 7.4 to -1.7 µmol · kg-1 · min-1 (P < 0.02). During insulin plus lipid/heparin infusion, FFA increased from 499 to 1,247 µmol/l (P < 0.001). EGP decreased 64% less than during insulin alone (-5.1 ± 0.7 vs. -13.7 ± 3.4 µmol · kg-1 · min-1). The decrease in GNG was not significantly different from the decrease of GNG during insulin alone (-2.6 vs. -4.5 µmol · kg-1 · min-1, not significant). In contrast, GL decreased 66% less than during insulin alone (-3.1 vs. -9.2 µmol · kg-1 · min-1, P < 0.05). We conclude that insulin suppressed EGP by inhibiting GL more than GNG and that elevated plasma FFA levels attenuated the suppression of EGP by interfering with insulin suppression of GL.

gluconeogenesis; endogenous glucose production; glucagon; euglycemic-hyperinsulinemic clamping; free fatty acid


This article has been cited by other articles:


Home page
DiabetesHome page
R. Basu, V. Chandramouli, B. Dicke, B. R. Landau, and R. A. Rizza
Plasma C5 Glucose-to-2H2O Ratio Does Not Provide an Accurate Assessment of Gluconeogenesis During Hyperinsulinemic-Euglycemic Clamps in Either Nondiabetic or Diabetic Humans
Diabetes, July 1, 2008; 57(7): 1800 - 1804.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. Lindegaard, C. Frosig, A. M. W. Petersen, P. Plomgaard, S. Ditlevsen, B. Mittendorfer, G. Van Hall, J. F.P. Wojtaszewski, and B. K. Pedersen
Inhibition of Lipolysis Stimulates Peripheral Glucose Uptake but Has No Effect on Endogenous Glucose Production in HIV Lipodystrophy
Diabetes, August 1, 2007; 56(8): 2070 - 2077.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. B. Krag, L. C. Gormsen, Z. Guo, J. S. Christiansen, M. D. Jensen, S. Nielsen, and J. O. L. Jorgensen
Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics
Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E920 - E927.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Basu, C. Dalla Man, M. Campioni, A. Basu, G. Klee, G. Toffolo, C. Cobelli, and R. A. Rizza
Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction.
Diabetes, July 1, 2006; 55(7): 2001 - 2014.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. E. Carey, J. Gerrard, G. W. Cline, C. Dalla Man, P. T. English, M. J. Firbank, C. Cobelli, and R. Taylor
Acute inhibition of lipolysis does not affect postprandial suppression of endogenous glucose production
Am J Physiol Endocrinol Metab, December 1, 2005; 289(6): E941 - E947.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
V. Ferchaud-Roucher, E. Pouteau, H. Piloquet, Y. Zair, and M. Krempf
Colonic fermentation from lactulose inhibits lipolysis in overweight subjects
Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E716 - E720.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. Aftab Guy, D. Sandoval, M. A. Richardson, D. Tate, and S. N. Davis
Effects of glycemic control on target organ responses to epinephrine in type 1 diabetes
Am J Physiol Endocrinol Metab, August 1, 2005; 289(2): E258 - E265.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. P. Harber, S. Schenk, A. L. Barkan, and J. F. Horowitz
Alterations in carbohydrate metabolism in response to short-term dietary carbohydrate restriction
Am J Physiol Endocrinol Metab, August 1, 2005; 289(2): E306 - E312.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
Z. T. Bloomgarden
Second World Congress on the Insulin Resistance Syndrome: Mediators, pediatric insulin resistance, the polycystic ovary syndrome, and malignancy
Diabetes Care, July 1, 2005; 28(7): 1821 - 1830.
[Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. A. DiCostanzo, M. C. Moore, M. Lautz, M. Scott, B. Farmer, C. A. Everett, J. G. Still, A. Higgins, and A. D. Cherrington
Simulated first-phase insulin release using Humulin or insulin analog HIM2 is associated with prolonged improvement in postprandial glycemia
Am J Physiol Endocrinol Metab, July 1, 2005; 289(1): E46 - E52.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Basu, A. Basu, C. M. Johnson, W. F. Schwenk, and R. A. Rizza
Insulin Dose-Response Curves for Stimulation of Splanchnic Glucose Uptake and Suppression of Endogenous Glucose Production Differ in Nondiabetic Humans and Are Abnormal in People With Type 2 Diabetes
Diabetes, August 1, 2004; 53(8): 2042 - 2050.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. N. Clore, J. S. Stillman, J. Li, S. J. D. O'Keefe, and J. R. Levy
Differential effect of saturated and polyunsaturated fatty acids on hepatic glucose metabolism in humans
Am J Physiol Endocrinol Metab, August 1, 2004; 287(2): E358 - E365.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Faraj and K. Cianflone
Differential regulation of fatty acid trapping in mouse adipose tissue and muscle by ASP
Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E150 - E159.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. Basu, W. F. Schwenk, and R. A. Rizza
Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes
Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E55 - E62.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. Muurling, A. M. van den Hoek, R. P. Mensink, H. Pijl, J. A. Romijn, L. M. Havekes, and P. J. Voshol
Overexpression of APOC1 in obob mice leads to hepatic steatosis and severe hepatic insulin resistance
J. Lipid Res., January 1, 2004; 45(1): 9 - 16.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. C. Moore, S. Satake, M. Lautz, S. A. Soleimanpour, D. W. Neal, M. Smith, and A. D. Cherrington
Nonesterified Fatty Acids and Hepatic Glucose Metabolism in the Conscious Dog
Diabetes, January 1, 2004; 53(1): 32 - 40.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. P. Kim, M. Ellmerer, G. W. Van Citters, and R. N. Bergman
Primacy of Hepatic Insulin Resistance in the Development of the Metabolic Syndrome Induced by an Isocaloric Moderate-Fat Diet in the Dog
Diabetes, October 1, 2003; 52(10): 2453 - 2460.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Kashyap, R. Belfort, A. Gastaldelli, T. Pratipanawatr, R. Berria, W. Pratipanawatr, M. Bajaj, L. Mandarino, R. DeFronzo, and K. Cusi
A Sustained Increase in Plasma Free Fatty Acids Impairs Insulin Secretion in Nondiabetic Subjects Genetically Predisposed to Develop Type 2 Diabetes
Diabetes, October 1, 2003; 52(10): 2461 - 2474.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Adkins, R. Basu, M. Persson, B. Dicke, P. Shah, A. Vella, W. F. Schwenk, and R. Rizza
Higher Insulin Concentrations Are Required to Suppress Gluconeogenesis Than Glycogenolysis in Nondiabetic Humans
Diabetes, September 1, 2003; 52(9): 2213 - 2220.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. Chandran, S. A. Phillips, T. Ciaraldi, and R. R. Henry
Adiponectin: More Than Just Another Fat Cell Hormone?
Diabetes Care, August 1, 2003; 26(8): 2442 - 2450.
[Full Text] [PDF]


Home page
QJMHome page
C.J. Malkin, P.J. Pugh, T.H. Jones, and K.S. Channer
Testosterone for secondary prevention in men with ischaemic heart disease?
QJM, July 1, 2003; 96(7): 521 - 529.
[Full Text] [PDF]


Home page
Diabetes CareHome page
Z. T. Bloomgarden
Fat Metabolism and Diabetes: 2003 American Diabetes Association Postgraduate Course
Diabetes Care, July 1, 2003; 26(7): 2198 - 2203.
[Full Text] [PDF]


Home page
DiabetesHome page
P. Staehr, O. Hother-Nielsen, B. R. Landau, V. Chandramouli, J. J. Holst, and H. Beck-Nielsen
Effects of Free Fatty Acids Per Se on Glucose Production, Gluconeogenesis, and Glycogenolysis
Diabetes, February 1, 2003; 52(2): 260 - 267.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. Boden, P. Cheung, and C. Homko
Effects of Acute Insulin Excess and Deficiency on Gluconeogenesis and Glycogenolysis in Type 1 Diabetes
Diabetes, January 1, 2003; 52(1): 133 - 137.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online